Endogenous IL-12 triggers an antiangiogenic program in melanoma cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 10, 2007, Pages 3996-4001

  Airoldi, Irma ^a   Di Carlo, Emma ^b   Cocco, Claudia ^a   Taverniti, Giuseppe ^c   D'Antuono, Tommaso ^b   Ognio, Emanuela ^c   Watanabe, Morihiro ^d   Ribatti, Domenico ^e   Pistoia, Vito ^a  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d NATIONAL CANCER INSTITUTE   (United States)

^e UNIVERSITY OF BARI   (Italy)

Author keywords

Angiogenesis; Cytokines; Tumor immunology

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; INTERLEUKIN 12 RECEPTOR; RECOMBINANT PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BLOOD LEVEL; CANCER GROWTH; CANCER INHIBITION; CANCER TRANSPLANTATION; CARCINOGENICITY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; HYDRODYNAMICS; IL12RB2 GENE; IMMUNOMODULATION; IMMUNOSURVEILLANCE; INTERFERON PRODUCTION; KNOCKOUT MOUSE; MELANOMA CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TARGET CELL; TUMOR SUPPRESSOR GENE; ANIMAL; CHICKEN; EXPERIMENTAL MELANOMA; MELANOMA; METABOLISM; MOUSE MUTANT; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; SKIN TUMOR;

ANIMALIA; MUS;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CHICKENS; GENES, TUMOR SUPPRESSOR; INTERLEUKIN-12; MELANOMA; MELANOMA, EXPERIMENTAL; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, INTERLEUKIN-12; RECOMBINANT PROTEINS; SKIN NEOPLASMS;

EID: 34247277021     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0609028104     Document Type: Article

References (47)

1. Trinchieri G (2003) Nat Rev Immunol 3:133-146.
2. Trinchieri G, Pflanz S, Kastelein RA (2003) Immunity 19:641-644.
3. Hunter CA (2005) Nat Rev Immunol 5:521-531.
4. Wolf SF, Temple PA, Kobayashi M, Young D, Dicig M, Lowe L, Dzialo R, Fitz L, Ferenz C, Hewick RM, et al. (1991) J Immunol 146:3074-3081.
5. Chua AO, Chizzonite R, Desai BB, Truitt TP, Nunes P, Minetti LJ, Warrier RR, Presky DH, Levine JF, Gately MK, et al. (1994) J Immunol 153:128-136.
6. Presky DH, Yang H, Minetti LJ, Chua AO, Nabavi N, Wu CY, Gately MK, Gubler U (1996) Proc Natl Acad Sci USA 93:14002-14007.
7. Manetti R, Gerosa F, Giudizi MG, Biagiotti R, Parronchi P, Piccinni MP, Sampognaro S, Maggi E, Romagnani S, Trinchieri G, et al. (1994) J Exp Med 179:1273-1283.
8. Magram J, Sfarra J, Connaughton S, Faherty D, Warrier R, Carvajal D, Wu CY, Stewart C, Sarmiento U, Gately MK (1996) Ann NY Acad Sci 795:60-70.
9. Stern AS, Podlaski FJ, Hulmes JD, Pan YC, Quinn PM, Wolitzky AG, Familletti PC, Stremlo DL, Truitt T, Chizzonite R, et al. (1990) Proc Natl Acad Sci USA 87:6808-6812.
10. Airoldi I, Gri G, Marshall JD, Corcione A, Facchetti P, Guglielmino R, Trinchieri G, Pistoia V (2000) J Immunol 165:6880-6888.
11. Brunda MJ, Luistro L, Warrier RR, Wright RB, Hubbard BR, Murphy M, Wolf SF, Gately MK (1993) J Exp Med 178:1223-1230.
12. Colombo MP, Trinchieri G (2002) Cytokine Growth Factor Rev 13:155-168.
13. Smyth MJ, Taniguchi M, Street SE (2000) J Immunol 165:2665-2670.
14. Airoldi I, Di Carlo E, Banelli B, Moserle L, Cocco C, Pezzolo A, Sorrentino C, Rossi E, Romani M, Amadori A, Pistoia V (2004) J Clin Invest 113:1651-1659.
15. Nanni P, Nicoletti G, De Giovanni C, Landuzzi L, Di Carlo E, Cavallo F, Pupa SM, Rossi I, Colombo MP, Ricci C, et al. (2001) J Exp Med 194:1195-1205.
16. Voest EE, Kenyon BM, O'Reilly MS, Truitt G, D'Amato RJ, Folkman J (1995) J Natl Cancer Inst 87:581-586.
17. Sgadari C, Angiolillo AL, Tosato G (1996) Blood 87:3877-3882.
18. Majewski S, Marczak M, Szmurlo A, Jablonska S, Bollag W (1996) J Invest Dermatol 106:1114-1118.
19. Wu C, Wang X, Gadina M, O'Shea JJ, Presky DH, Magram J (2000) J Immunol 165:6221-6228.
20. Airoldi I, Di Carlo E, Cocco C, Sorrentino C, Fais F, Cilli M, D'Antuono T, Colombo MP, Pistoia V (2005) Blood 106:3846-3853.
21. Patarroyo M, Tryggvason K, Virtanen I (2002) Semin Cancer Biol 12:197-207.
22. Tanaka K, Hiraiwa N, Hashimoto H, Yamazaki Y, Kusakabe M (2004) Int J Cancer 108:31-40.
23. Nguyen NM, Kelley DG, Schlueter JA, Meyer MJ, Senior RM, Miner JH (2005) Dev Biol 282:111-125.
24. Deroanne C, Vouret-Craviari V, Wang B, Pouyssegur J (2003) J Cell Sci 116:1367-1376.
25. Favier B, Alam A, Barron P, Bonnin J, Laboudic P, Fons P, Mandron M, Herault J-P, Neufeld G, Savi P, et al. (2006) Blood 108:1243-1250.
26. Kertesz N, Krasnoperov V, Reddy R, Leshanski L, Kumar SR, Zozulya S, Gill PS (2006) Blood 107:2330-2338.
27. Kwabi-Addo B, Ozen M, Ittmann M (2004) Endocr Relat Cancer 11:709-724.
28. Noren NK, Lu M, Freeman AL, Koolpe M, Pasquale EB (2004) Proc Natl Acad Sci USA 101:5583-5588.
29. Ogawa K, Pasqualini R, Lindberg RA, Kain R, Freeman AL, Pasquale EB (2000) Oncogene 19:6043-6052.
30. Shin JW, Min M, Larrieu-Lahargue F, Canron X, Kunstfeld R, Nguyen L, Henderson JE, Bikfalvi A, Detmar M, Hong YK (2006) Mol Biol Cell 17:576-584.
31. Shintani Y, Takashima S, Asano Y, Kato H, Liao Y, Yamazaki S, Tsukamoto O, Seguchi O, Yamamoto H, Fukushima T, et al. (2006) EMBO J 25:3045-3055.
32. Harfouche R, Hussain SN (2006) Am J Physiol 291:H1635-H1645.
33. Salcedo R, Young HA, Ponce ML, Ward JM, Kleinman HK, Murphy WJ, Oppenheim JJ (2001) J Immunol 166:7571-7578.
34. Tanjore H, Kalluri R (2006) Am J Pathol 168:715-717.
35. Melani C, Stoppacciaro A, Foroni C, Felicetti F, Care A, Colombo MP (2004) Cancer Immunol Immunother 53:600-608.
36. Sales KJ, Katz AA, Howard B, Soeters RP, Millar RP, Jabbour HN (2002) Cancer Res 62:424-432.
37. Mitola S, Strasly M, Prato M, Ghia P, Bussolino F (2003) J Immunol 171:3725-3733.
38. Kawamori T, Osta W, Johnson KR, Pettus BJ, Bielawski J, Tanaka T, Wargovich MJ, Reddy BS, Hannun YA, Obeid LM, Zhou D (2006) FASEB J 20:386-388.
39. Takahashi M, Hayashi K, Yoshida K, Ohkawa Y, Komurasaki T, Kitabatake A, Ogawa A, Nishida W, Yano M, Monden M, Sobue K (2003) Circulation 108:2524-2529.
40. Koo BH, Kim DS (2003) J Biol Chem 278:52578-52586.
41. Dias S, Boyd R, Balkwill F (1998) Int J Cancer 78:361-365.
42. Duda DG, Sunamura M, Lozonschi L, Kodama T, Egawa S, Matsumoto G, Shimamura H, Shibuya K, Takeda K, Matsuno S (2000) Cancer Res 60:1111-1116.
43. Zaki MH, Shane RB, Geng Y, Showe LC, Everetts SE, Presky DH, Wysocka M, Moore JS, Rook AH (2001) J Invest Dermatol 117:119-127.
44. Zaki MH, Wysocka M, Everetts SE, Wang KS, French LE, Ritz J, Rook AH (2002) J Invest Dermatol 118:366-371.
45. Gorelik E, Edwards RP, Feng X, Marrangoni AM, Grandis JR, Drenning SD, Velikokhatnaya L, Kwon JA, Lokshin AE (2004) Int J Cancer 112:620-627.
46. Ribatti D, Gualandris A, Bastaki M, Vacca A, Iurlaro M, Roncali L, Presta M (1997) J Vasc Res 34:455-463.
47. Liu F, Song Y, Liu D (1999) Gene Ther 6:1258-1266.